Skip to main content

Table 2 Functional outcome of the 2 patient groups

From: Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment

Modified Harris Hip Score

All

Teriparatide-treated

Non-Teriparatide- treated

p-value

Postoperative 3 months

67.14

72 (70)

62.29 (65)

0.114

Postoperative 6 months

73.64

79 (78)

68.29 (73)

0.021*

Postoperative 1 year

81.57

84.29 (88)

78.86 (83)

0.384

Numerical Rating Scale

 Postoperative

7.38

7.25 (7)

7.5 (7.5)

0.582

 Postoperative 3 months

3.94

3.75 (3.5)

4.13 (4)

0.413

 Postoperative 6 months

3.25

2.63 (3)

3.88 (4)

0.042*

 Postoperative 9 months

1.94

1.38 (1.5)

2.5 (3)

0.139

 Postoperative 1 year

1.13

1 (1)

1.25(1)

0.628

 Recovery to pre-OP walking ability (%)

7 (53.8%)

5 (71.4%)

2 (33.3%)

0.217

  1. *p value < 0.05
  2. Data presented as mean (median)